Newborn Screening

Regular Off Off
A peice of equipment within the Laboratory that screens for conditions

The department of Clinical Biochemistry provide the Newborn Bloodspot Screening service for a large part of the South West Region. Testing is undertaken on filter paper bloodspots which are collected from babies between 5 and 8 days of age. Our UKAS accredited laboratory currently screens approximately 42,000 babies each year for nine conditions:

  • Sickle cell disease (SCD)
  • Cystic Fibrosis (CF)
  • Congenital Hypothyroidism (CHT)
  • Inherited Metabolic Diseases:
    • Phenylketonuria (PKU)
    • Medium-chain acyl-CoA dehydrogenase deficiency (MCADD)
    • Maple syrup urine disease (MSUD)
    • Isovaleric acidaemia (IVA)
    • Glutaric aciduria type 1 (GA1)
    • Homocystinuria (pyridoxine unresponsive) (HCU)

Early detection through screening and prompt treatment significantly reduces the morbidity and mortality associated with these conditions.
The newborn screening bloodspot programme is provided in close collaboration with health care professionals throughout the region.

Information for public and professionals regarding the SCID evaluation.

Screening for SCD is provided with the department of Haematology at North Bristol NHS Trust (NBT) and Cystic Fibrosis with the Bristol Genetics Laboratory

The screening laboratory works very closely with the South West Regional Metabolic Biochemistry laboratory which provides diagnostic testing to support the newborn screening programmes and monitoring of patients identified though the Inherited Metabolic Disease screening programmes. Bloodspot testing for PKU, hypothyroidism (TSH) and a monitoring service for Congenital Adrenal Hyperplasia (17-OHP) is also available.

In early 2014 we began uploading all of our results to the Newborn Blood Spot Failsafe Solution (NBSFS). This is a national web-based solution which allows maternity units, child health record departments, and screening laboratories to verify the screening status of any baby registered in England. It enables easy early identification of those babies who have had no blood spot card received in the laboratory, making it less likely that any babies will miss screening, and also promotes timeliness of repeat sampling.

Laboratory Visits

We offer half-day training sessions to midwives, health visitors, dieticians, nurses, doctors and other healthcare professionals involved in the collection of bloodspots. Please contact us to arrange a visit.

Please see below for responses to our most recent user survey

Key Contacts

Dr Helena Kemp
Director of Newborn Screening & Consultant Chemical Pathologist
Telephone: 0117 4148425

Maryam Khan
Principal Clinical Scientist
Telephone: 0117 4148418

Emma Smith-Thomas
Senior Clinical Scientist
Telephone: 0117 4148427

Dr Sophie Otton
Consultant Haematologist
Telephone: 0117 4148359

Grace VanDerMee
Lead Biomedical Scientist - Haematology
Telephone: 0117 4148356

Rebecca Whittington
Principal Clinical Scientist - Genetics
Telephone: 0117 4146175

Clare Le Masurier
Senior Biomedical Scientist
Telephone: 0117 4148430

Bryony Wright
Senior Biomedical Scientist
Telephone: 0117 4148346

Contact Newborn Screening

Newborn Screening Laboratory (Bristol)
PO Box 407
Bristol
BS9 0EA

Email: newbornscreening@nbt.nhs.uk
Telephone: 0117 414 8412
 

Opening times: 9am - 5pm Monday - Friday excluding bank holidays.

Clinical advice & interpretation is available during working hours.

Access the NHS Blood Spot Screening Programme Centre

Newborn Screening

Metabolic Biochemistry

Regular Off Off

The Metabolic Biochemistry Laboratory (previously Biochemical Genetics) at Southmead Hospital provides a regional diagnostic and monitoring service for the investigation of inherited metabolic diseases. Routine analyses performed include urine organic acids (including quantitative methylmalonic acid, if required), bloodspot/plasma acylcarnitines (including free carnitine), plasma/urine/CSF quantitative amino acids, qualitative galactosaemia screening test, plasma free fatty acids and 3-hydroxybutyrate.

In addition, the laboratory provides specialist testing for the investigation of peroxisomal disorders (plasma very long chain fatty acid analysis, including pristanic and phytanic acids), Smith-Lemli-Opitz syndrome (plasma 7-dehydrocholesterol and 8-dehydrocholesterol)

The Metabolic Biochemistry department is a Centre for Galactosemia investigations and offers a variety of tests for the diagnosis and monitoring of disorders of galactose metabolism including:

  • first line galactosaemia screens,
  • quantitative galactose-1-phosphate uridyltransferase activity for confirmation of classical galactosaemia;
  • urine galactitol for screening and monitoring of galactokinase deficiency or screening for classical galactosaemia if infant has been transfused; 
  • galactokinase activity for confirmation of galactokinase deficiency;
  • galactose-1-phosphate for monitoring treatment of classical galactosaemia.

The Metabolic Biochemistry Laboratory at Southmead Hospital is a member of the UK National Metabolic Biochemistry Network (MetBioNet). 

The Metabolic Biochemistry laboratory works very closely with the Southwest Newborn Screening Laboratory to aid in the diagnostic testing to support the newborn screening programmes and monitoring of patients identified though the Inherited Metabolic Disease screening programmes. Bloodspot monitoring for PKU (Phenylalanine and tyrosine) and CAH (17-OHP) for known patients and testing for hypothyroidism on bloodspot (TSH)

We provide a comprehensive advisory service and welcome enquiries to discuss appropriate patient investigation and result interpretation. Clinical and laboratory advice is available during working hours, via contacts listed.

Details of Sample Requirements and Transport can be found under “Requesting” and “Test Information” via the menu at the top of this page.

For any urgent analyses or additional testing on samples already received, please telephone the laboratory to discuss.

CSF amino acid reference ranges currently in use
CSF analyte<6 months6m - 1 year1 - 5 years5 years
Glycine2-152-102-102-10
Threonine21-11512-5512-5512-55
Serine32-8027-6324-5608-44
Alanine18-5913-4113-4113-41

(Source: CSF amino acid reference intervals from the Cardiff Working Group, MetBioNet)

User Handbook

Request form


 

User Survey

Useful Links

National Metabolic Biochemistry Network (MetBioNet)
British Inherited Metabolic Diseases Group
Cardiff Porphyria Service

Metabolic Biochemistry

Dr Helena Kemp, Consultant Chemical Pathologist
helena.kemp@nbt.nhs.uk
helenakemp@nhs.net
Tel: 0117 4148425

Maryam Khan, Principal Clinical Scientist
maryam.khan@nbt.nhs.uk
maryam.khan2@nhs.net
Tel: 0117 4148418

Bryony Wright, Senior Biomedical Scientist
bryony.wright@nbt.nhs.uk
Tel: 0117 4148430/4148346

Clare Le Masurier, Senior Biomedical Scientist
clare.lemasurier@nbt.nhs.uk 
clare.lemasurier1@nhs.net 
Tel: 0117 4148430/4148346

Emma Smith-Thomas, Senior Clinical Scientist
emma.smith-thomas@nbt.nhs.uk
Tel: 0117 4148427

Southwest Newborn Screening and Metabolic Biochemistry Laboratory
Pathology Sciences Building
Southmead Hospital
Westbury-on-Trym
Bristol,  BS10 5NB
Telephone: 0117 4148346

NBS&MetabolicBiochemistry@nbt.nhs.uk

 

Opening times: 9am – 5pm Monday – Friday excluding Bank Holidays

National Metabolic Biochemistry Network includes national guidelines for investigation of inherited metabolic disorders.

Biochemical Genetics

Transport

Regular Off Off

Within North Bristol NHS Trust (NBT)

  • Samples for Blood Sciences: (Biochemistry, Haematology and Immunology) and Infection Sciences: (Bacteriology, Virology, Antimicrobial assays (ARL) and Mycology (MRU)) should be sent via the air tube unless the sample type/reason appears in the list below.
  • Samples that MUST NOT be sent via the air tube include:
    • Urine for TB or suspected TB.
    • Viral haemorrhagic fever.
    • Histology or cytology.
    • Category 4 microbes.
    • Volumes over 100ml.
    • Samples which need to remain frozen (e.g. via dry ice).
    • Samples which need to be kept warm - special flasks are available for the transport of samples which have essential requirements to be kept warm (i.e. cryoglobulins, patients with cold agglutinins) - contact the Immunology or Haematology departments for these.
  • Samples for COVID-19 can be sent via the air tube, but these MUST be double-bagged, sealed and sent in a new leak-proof carrier.
  • Blood components and products will be transported in an appropriate, validated container packed by the Transfusion Laboratory.For Primary Care locations where Pathology Services are provided by North Bristol NHS Trust (NBT)

Sample collections from external locations (e.g. primary care, community) are made by the Pathology’s appointed medical courier Delivery Direct Logistics (DDL). For queries regarding this service please email Allison Brixey, Blood Sciences Manager, Allison.Brixey@nbt.nhs.uk.

What is Normal-Pressure Hydrocephalus?

Regular Off Off

This information is for patients referred to the the Adult Hydrocephalus team at North Bristol NHS Trust as a brain scan has shown features of Normal-Pressure Hydrocephalus. 

What is Normal-Pressure Hydrocephalus (NPH)?

Cerebrospinal Fluid (CSF) is produced continually in the ventricles (cavities of the brain). Normally CSF circulates through the brain acting as a protective cushion and providing nutrients. NPH affects people aged over 60 and happens when the fluid becomes poorly absorbed, causing an abnormal amount of CSF to build up in the ventricles. This does not cause high pressure in the brain, but it does affect its function, and a person’s quality of life. 

What are the symptoms? 

Mobility and balance

  • Difficulty taking large steps, and shuffling when walking.
  • Unable to turn quickly due to losing balance.
  • Falling backwards, sometimes when getting out of a chair.
  • A general feeling of unsteadiness when walking.

Memory and thinking

  • Slowness in thinking, and problems with attention.
  • Memory difficulties.
  • Changes in behaviour, loss of motivation.
  • Worsening mood, depression, and anxiety.

Urinary incontinence

  • Increased urgency to pass urine (go to the toilet).
  • Sudden leakage of urine.
  • Not making it to the toilet in time.

Why am I being referred to the Adult Hydrocephalus team? 

You were referred by a specialist doctor or GP following a brain scan which may have shown features of NPH. We are a team of skilled nurses, doctors, advanced clinical practitioners, physiotherapists, and neuropsychologists. We will do multiple assessments (walking and memory tests) to see if you would benefit from further assessment and treatment by our team. 

Physiotherapy-led prehab service

Before being seen in the Hydrocephalus Clinic, we offer patients the opportunity to discuss the diagnosis with a Specialist Physiotherapist. We will phone you once your referral has been accepted and can advise you on lifestyle choices you can make to optimise your health while waiting for your face-to-face review.

If you feel you need further advice, you can phone the hydrocephalus advice line on 0117 414 6613. This is for non-urgent queries.

How is it diagnosed? 

You have been  directed to this page as we suspect you have NPH but the diagnosis has not been confirmed.

NPH is a clinical diagnosis that cannot be confirmed with brain imaging (scans) alone. We need to do other tests to confirm the diagnosis.

Lumbar drain

A lumbar drain is a procedure that allows us to see if your symptoms are improved by temporarily removing cerebrospinal fluid (CSF) from your brain. 

The lumbar drain is a piece of flexible tubing that is inserted into the lower part of the spinal canal. The tubing is connected to a drain which allows us to control how much CSF is drained. If you benefit from the drain, you may be considered for a permanent shunt. 

Not everyone is suitable for a lumbar drain, we will review your brain imaging, and if this is the case we will discuss alternative options with you. 

 

Diagram of person from behind, lying on side, with lumbar drain inserted into lower back

 

CSF shunting

A tube is inserted that diverts fluid from the ventricles of the brain to the abdomen through a small valve. This is connected to another tube passed under the skin to the abdomen. This valve can be adjusted to control the flow of the fluid from your brain. 

We will the reassess your symptoms through various tests to confirm if the procedure has been beneficial. At this stage we will be able to confirm the NPH diagnosis. 

Diagram of person with CSF shunt going from ventricles of brain do drain the peritoneal cavity

Follow-up

If you do have a CSF shunt inserted you will be followed up regularly to assess your progress and make sure your symptoms are improved.

During these appointments we complete walking and memory tests to monitor for changes in your symptoms.

What can I do whilst on the waiting list for assessment? 

Due to the symptoms of NPH, you may find it more challenging to do your day-to-day activities such as going to the shops, going on walk, engaging in hobbies, and social activities. However there are certain things you can do to help maintain your physical health during this time. 

Physical activity

NPH can make walking much more challenging, however continuing to move is extremely important. Like many things in life if you don’t use it, you can lose it.

Going for a walk a few times a week is an excellent way to keep yourself fit and strong. If you like to do more structured exercise like exercise classes, then this is also encouraged.

Practical tips: going for a daily walk of 20-30 minutes will make sure you meet the government guidelines for weekly activity. If you are very unsteady, you may find it helpful to use a walking aid such as a walking stick or 4 wheeled walker.

You can speak to your GP about referral to a Community Physiotherapist to provide advice and guidance about maintaining your fitness and reducing your risk of falls.

Occupational therapists can give expert advice and provide equipment to ensure you are able to complete your everyday tasks, speak to your GP about getting referred.

Incontinence

It can be challenging to live with the urinary symptoms of NPH without advice and guidance. Speaking to your GP about referral to incontinence services can be a useful way to get professional advice on how to maintain your quality of life with these symptoms.

Practical tips: keep access to the toilet clutter free and remove any trip hazards to prevent risk of falling if you need to hurry. Consider a commode or urine bottle in your bedroom to use at night.

Memory and cognitive impairment

This type of hydrocephalus can change your brain’s ability to stay focus, remain organised, and can affect your memory. These symptoms can develop relatively quickly compared to other forms of dementia - over just a few months.

Practical tips: speaking to your GP/pharmacist about medication tools such a dosette box can prevent medication errors. Diaries and calendars be useful for keeping track of appointments and routines, as well as whiteboards for writing lists and reminders.

Family and friends

We recommend including your family and friends in this process, showing them this page may help them understand the condition and how the symptoms affect your life.

If you have any further questions or concerns at any stage in the process, please contact the Adult Hydrocephalus team on the details below. If it is out of hours, please contact your GP or local Emergency Department.

How to contact us

0117 414 6613

24 hour answer machine available
Monday - Friday
08:00 - 16:00

Adult Hydrocephalus Team

  • Mr Richard Edwards
  • Kelly Wride
  • Cecily King
  • Katie Holdsworth
  • Jacob Spong

© North Bristol NHS Trust. This edition published November 2024. Review due November 2027. NBT003702

Support your local hospital charity

Southmead Hospital Charity logo

Find out about what we do and how you can support us. 

Fibreoptic Endoscopic Evaluation of Swallowing (FEES)

Regular Off Off

This information is for patients who have been referred for a FEES examination. This page explains the process. 

What is FEES? 

FEES (Fibreoptic Endoscopic Evaluation of Swallowing) is an examination that looks at how you swallow. It aims to find out how your muscles work when you swallow and what might be causing you any difficulties.

How will this help?

We use FEES to understand and help with swallowing problems. It allows us to see whether:

  • Food, drink, or saliva is going down the wrong way (into your airway).
  • Some food and drink consistencies are easier for you to swallow than others and why.
  • Your swallowing difficulties can be helped by altering the position of your head or body.
  • There are any other changes we can recommend that may help you.

How is this done?

Two Speech and Language Therapists (SLT) will do the procedure while you are sitting down. A small, lubricated, flexible camera will be placed into one nostril. When the end of the camera is passed just beyond the back of the nose, we get a clear view of your throat. You will be able to see the images if you choose.

We make a recording of the images so we can analyse it afterwards.

You may be given some food and drink. This is dyed with blue/green food colouring to help us see it. This is usually: 

  • Milky water.
  • Fruit puree.
  • Cake.
  • Biscuit.
  • Thickened drink.

If you have any food allergies or strong food dislikes, please tell your Speech and Language Therapist. You may bring in alternative food if you choose to. This part of the appointment will take up to 30 minutes.

Is the procedure safe? 

The procedure is safe with a low risk of complications or side effects.

Is it uncomfortable? 

Passing the camera through the nose can sometimes cause mild to moderate discomfort. The Speech and Language Therapist will reassure you through throughout the procedure. Local anaesthetic will not be used as this will affect your swallow. 

What happens next?

The Speech and Language Therapists will analyse the images whilst you wait in the waiting area. This could take up to to 30 minutes. You will then be invited back in to discuss what we have seen. 

We will also speak with you about what the results mean for your swallowing. You will leave with a summary of this information and a plan for follow-up if needed.

You can go home immediately after the appointment. The procedure should not affect your ability to drive.

How long does it take?

The whole appointment (including assessment and advice) should take no more than 90 minutes. Please be patient if there are any delays, we will keep you informed if this is it the case. 

Can I eat before my appointment?

Unless you have been advised otherwise, you can eat and drink a light meal before your appointment. If you are currently feeding through a tube, you can take your feeds as normal.

What happens after I leave?

Detailed results will be sent to all relevant healthcare professionals involved in your care. 

What do you do with the recordings? 

The images are saved electronically and kept securely for 8 years. 

Where can I find more information? 

If you have any questions, please contact your Speech and Language Therapist. 

When and where is the appointment?

Your appointment will be at:

Gate 36 (Pink Zone)
Brunel building
Southmead Hospital

You will receive a letter/email with the time and date.

Cancelling an appointment

Please tell us as soon as possible if you need to cancel your appointment by phoning the Speech and Language Therapy Department on 0117 414 5130.

© North Bristol NHS Trust. This edition published December 2024. Review due December 2027. NBT003751

Support your local hospital charity

Southmead Hospital Charity logo

Find out about what we do and how you can support us. 

Analytes

Regular Off Off

Benzylpenicilin (Penicillin G)

Gentamicin

As of 2nd December 2024, this test will be provided on the Clinical Biochemistry analytical platform, however clinical advice will still be offered by the Microbiology service 0117 4146222. Please see updated test information Gentamicin test page link.

Isoniazid (+ N-Acetyl-Isoniazid)

Sulphamethoxazole in (Co-trimoxazole)

Trimethoprim in (Co-trimoxazole)

Vancomycin

As of 2nd December 2024, this test will be provided on the Clinical Biochemistry analytical platform, however clinical advice will still be offered by the Microbiology service 0117 4146222. Please see updated test information Vancomycin test page link.

Antimicrobial Reference Laboratory Contact Details

Antimicrobial Reference Laboratory
Level 2, Phase 1, Pathology Sciences Building
Southmead Hospital
Westbury-on-Trym
Bristol
BS10 5NB

For General Enquiries and Results:

Telephone: 0117 4146269 or 0117 4146220
For Clinical Advice: 07802 720900
Fax: 0117 4146282
Email: arlenquiries@nbt.nhs.uk

Laboratory Hours

Monday to Friday 9am - 5.15pm, Saturday 9am - 12 noon

VIDEO: What is the FAST MRI DYAMOND study?

Regular Off Off
FAST MRI DYAMOND

 

Video Transcript

Have you recently received a letter from the NHS breast screening programme inviting you to come for your first screening mammogram?

The NHS provides a breast screening service because early detection of breast cancer saves lives.

The NHS screening programme has been using mammograms to detect cancer since 1988… But still, 30 women die of breast cancer every day in the UK.

The FAST MRI DYAMOND study is looking to see if a new form of MRI scan, called FAST MRI, can pick up aggressive cancers even earlier than mammograms can. 

The NHS already uses breast MRI to detect cancers, but only for women who have a very high likelihood of having breast cancer. For these women, MRI detects breast cancers earlier than mammograms and saves more lives.

The FAST MRI DYAMOND study will be the first UK study to offer a FAST MRI scan to women at normal or average risk, aged 50-52. People invited for their first screening mammogram can take part at 4 NHS breast screening services in England. (BristolCheltenhamSwindonTruroLondon (St George’s & King’s College).

Everyone’s breasts are different, and in addition to how breasts look and feel in real life, they also look different on mammograms.

At age 50-52, breasts can look completely white on mammograms. They can also look completely dark. Both appearances are normal, as are all the different combinations of white and dark in between. These differences are called mammographic density or breast density.

The problem is that breast density can make a small cancer difficult to spot on a mammogram. Breast cancers tend to show as white on mammograms, so you can see how much easier a cancer would be to spot on the dark mammogram on the left than on the white mammogram on the right.

Fortunately, however, FAST MRI works well at detecting small cancers for women of all breast densities. The pink arrow highlights what a cancer, that was completely invisible on the mammogram, looks like on FAST MRI.

Breast screening with mammograms already saves around 1,300 lives each year in the UK by finding cancers that are too small to feel or see. 

FAST MRI could find cancers even earlier for women and our research is designed to find out which women would benefit from breast screening with FAST MRI through finding breast cancer even earlier than mammograms.

We want to find breast cancers earlier because:

  • finding cancer early makes it more likely that treatment will be successful
  • finding cancer early makes it less likely that a mastectomy will be needed
  • finding cancer early makes it more likely that the cancer will be cured.

The only way to discover your breast density is to have a mammogram.

The FAST MRI DYAMOND study wishes to offer a FAST MRI scan to 1000 people who all have average breast density. At age 50-52, four out of every 10 women will have average breast density and could join the FAST MRI DYAMOND Study to have a FAST MRI scan. 

We can only find out whether you can join the study if you give us your contact details and let us know you are happy for us to use your mammogram to measure your breast density.

Research is fundamental to improving treatment and care for patients and the public but it is your choice whether you join the study or not.

If you are having your first screening mammogram and would like to learn more about the FAST MRI DYAMOND study, please fill in a FAST MRI DYAMOND consent to be contacted form, either online or at your mammogram appointment. 

This is the web address of the online form. 

If you would like to ask any questions at all, you will find the telephone number for the nurse from your local research team below this video along with the link to the online form.

Thank you for taking the time to watch this film. Thank you for helping us with this research.

Interested in taking part?

To view the Patient Information leaflet and Consent form, please visit the study website.

DYAMOND web banner (1).png

Support for External Funding Applications

Regular Off Off

The Research Development & Grants Team can provide you with a range of support at every stage of your grant application/project development.

Please contact ResearchGrants@nbt.nhs.uk at the earliest opportunity. 

Grant development support includes:

  • Advising on the most appropriate funder/funding stream
  • Deciding which institution will Host and Sponsor your grant
  • Advising on and facilitating Public and Patient Involvement & Engagement
  • Signposting to wider support services
  • Supporting collaborations
  • Liaising with external organisations/companies and obtaining external costs
  • Providing a full grant costing for non-commercial and investigator-led projects. This includes NHS site costs (and supporting your SoECAT submission, where applicable). 
  • Critical, pre-submission reviews
  • Feasibility sense checks
  • Support statements
  • Intellectual Property advice
  • Proof reading
  • Online application form entry

It takes time to fully develop a research project and to cost a grant accurately. All requests to NBT to cost a research grant application must be made well in advance of the funder’s submission deadline. The time required to achieve a high-quality submission can depend greatly on the type of funder and project.

We recommend that you contact the Research Development & Grants Team at ResearchGrants@nbt.nhs.uk, at the earliest opportunity – as soon as you begin to develop a research project – so that we can provide you with the most comprehensive support. 

Once your project is funded, our team can support you with grant set-up and management. This includes: contracting, financial management, protecting Intellectual Property, reports and external communications.

View Our Research

Doctor conducting research at NBT

Explore the ground-breaking research currently taking place at North Bristol NHS Trust.

About Research & Development

NBT Researcher

Find out more about our research and how we're working to improve patient care.

Contact Research

Research & Development
North Bristol NHS Trust
Level 3, Learning & Research building
Southmead Hospital
Westbury-on-Trym
Bristol, BS10 5NB

Telephone: 0117 4149330
Email: research@nbt.nhs.uk

Internal Funding Opportunities

Regular Off Off

The Research & Development Office administer a number of internal funding opportunities. 

These are available to all NBT staff with a research idea that they want to develop into a project. 

We frequently make awards for small research projects, as well as personal awards for those wanting to pursue a career including research. Below are some of the funding options currently available. 

To apply, or for more information, contact: ResearchGrants@nbt.nhs.uk.

Research Capability Funding (RCF)

Funding to back-fill your time to develop research ideas into funded grants

Research Capability Funding (RCF) is a research funding stream made available by the National Institute of Health Research (NIHR) to help research-active NHS organisations attract, develop and retain high-quality research, clinical and support staff. North Bristol NHS Trust (NBT) has two rolling calls for applications, as well as an annual Research Infrastructure call: 

Early Career/Early-Stage Research Funding – Open for Applications

Applications are welcomed from NBT staff members wishing to fund their time to develop a research idea of relevance to the NHS and of benefit to patients. This rolling funding call is specifically aimed at staff substantively employed by NBT from non-medic staffing groups such as nurses, midwives, Allied Health Professionals and scientific and technical services who do not currently have protected time for research activity within their job plan. 

No prior experience of research is necessary as R&D will provide you with mentorship and support to scope out your research idea and explore the potential for developing this into a funded research project.

Standard Call

Applications are welcomed from NBT staff members who are actively working towards an NIHR grant(s) for submission within the next 12 months. This is a rolling call, and applications are welcomed at any time during the year. 

Applicants are strongly encouraged to contact R&D and the Research Support Service (RSS) to gain guidance on the various NIHR funding streams before applying for this call. NIHR applications, developed with support from RCF, will be led and hosted by NBT, supporting NBT’s excellent reputation in research and positively impacting NBT’s research portfolio.

Funding for delivering small research projects

NBT R&D Strategy recognises the importance of building research capacity. Therefore, funds from centralised charitable donations continue to support the Southmead Hospital Charity Springboard Research Fund.

Southmead Hospital Charity Springboard Research Fund

This fund supports NBT staff to undertake research projects (max. £25k per project) which could be directly implemented in the NHS, or feed into larger funding bids with the potential for future impact on the NHS. Applications are invited from NBT staff, including clinicians, nurses, midwives, and allied health professionals (AHPs) from any clinical area. 

Springboard supports staff with a range of experience, from staff with no prior research experience applying for their first research grant, through to an experienced researcher looking to undertake pilot, feasibility, or proof of concept work. 

R&D understand that applying for research funding can be daunting, but there is plenty of support available to help develop an application. Please contact researchgrants@nbt.nhs.uk as soon as possible to benefit from support

View Our Research

Doctor conducting research at NBT

Explore the ground-breaking research currently taking place at North Bristol NHS Trust.

About Research & Development

NBT Researcher

Find out more about our research and how we're working to improve patient care.

Contact Research

Research & Development
North Bristol NHS Trust
Level 3, Learning & Research building
Southmead Hospital
Westbury-on-Trym
Bristol, BS10 5NB

Telephone: 0117 4149330
Email: research@nbt.nhs.uk

Taking part in the FAST MRI DYAMOND study

Regular Off Off

Finding breast cancers early saves lives. 

We know that the earlier a breast cancer is diagnosed the better the outcomes for that patient. Mammograms (a type of breast x-ray) have been used for many years to check for breast cancers but may not always find cancers early enough to be helpful.  We would like to try out a new method of MRI, called “FAST MRI”. 

It is like the MRI scans you may have heard of or experienced, but takes much less time, about 3-5 minutes, which would make it suitable to offer to many more people.

What is the FAST MRI DYAMOND study? 

DYAMOND will test if a FAST MRI scan can detect cancers not seen on mammogram, in women with average density breasts. 

1000 women will be invited for a FAST MRI if:

  • they are aged around 50-52, 
  • their mammogram is clear 
  • their breast density is “average” (a computer measures this from mammogram images) 

What are the stages of the study?

Stage 1

This first stage includes looking at Mammogram images from your routine Breast Screening appointment. We check to see if you're able to have a FAST MRI scan by measuring your mammogram breast density and checking your screening records. Women with “average” breast density and a clear mammogram may be able to continue on to Stage 2 to have a FAST MRI scan. 

Please note, agreeing to take part in Stage 1 does not mean you will automatically have a FAST MRI scan. If the Stage 1 density grading shows you are eligible to take part in Stage 2, you will be invited and can then decide whether to take part or not. 

Stage 2

The second stage of the FAST MRI DYAMOND study involves having the FAST MRI scan. A member of the research team will contact you to give you the information about Stage 2.  They will discuss the study with you. If you can have the scan and would like to, they will book you a scan appointment. The scan itself takes just 3-5 minutes, but the whole appointment would last up to 45 minutes. 

Stage 1 - Patient Information

Who can take part?

Women with “average” breast density and a clear mammogram may be able to have a FAST MRI. To find this out, we are first inviting women to Stage 1 of the DYAMOND study. 

If you agree to take part in Stage 1, we will send your mammogram to the DYAMOND team at the Royal Surrey NHS Foundation Trust so that they can measure your breast density. We won’t send your mammogram to be measured for 10 working days after we receive your consent. This is in case you change your mind about participating. If you do, please let us know. 

The results will then be sent to Warwick Clinical Trials Unit, to be stored. 

If your mammogram is measured as anything other than average breast density, you will be looked after by the screening service, and you won’t be able to take part in this study. This is because we are only inviting people with “average” breast density to have a FAST MRI.

If your mammogram measurement is in the “average” breast density group, we will look at your mammogram screening results to check if the screening service says you need any further investigations. This is because in this study, we are only inviting people with clear mammograms to have a FAST MRI.

If you do need some further investigations, the screening service will contact you directly. You won’t be able to have the FAST MRI scan as part of this study. Instead, with your consent, we would like to access your screening and medical records to discover the outcome of your investigations. We will do this for up to 3 years after your first mammogram.

If the screening service says your mammogram needs no further investigations and you are in the average breast density group, we will send you information and an invitation to take part in Stage 2 of the study.

Agreeing to take part in Stage 1 does not mean you will automatically have a FAST MRI scan. If the Stage 1 density grading shows you are eligible to take part in Stage 2, you will be invited and can then decide whether to take part or not. 

Do I have to take part?

No, it’s up to you to decide whether to take part. If you do not want a FAST MRI scan or know you cannot have one, then you can let us know you don’t want to take part. Whether or not you choose to take part, be reassured that your clinical care will not be affected. You will still be offered your routine screening mammograms every 3 years until you turn 71.

Stage 2 - Patient Information

Why have I been asked to take part in this study?

Following your first mammogram, we invited you to take part in Stage 1 of the DYAMOND study: to measure your breast density and to check your breast screening results. Your images have now been checked and we think you could be eligible to join Stage 2 of the study to have a FAST MRI scan. 

Do I have to take part?

No, it’s up to you to decide whether to take part. If you choose not to, be reassured that your clinical care will not be affected. You will still be offered your routine screening mammograms every 3 years until you turn 71. 

What does taking part involve?

We have designed the study to be as convenient as it can be, so that as many people can be involved as possible. If you decide to take part, we will:

  • Ask you some questions about your health
  • Check that you can have a FAST MRI scan 
  • Book a FAST MRI scan at a time convenient to you
  • Ask you to complete a survey about your experience

Some people may also be invited to take part in an interview about their experience.

We expect a small proportion of people having a FAST MRI scan to be invited for another scan after a year or be referred for further investigations.

What do I do next if I am interested in taking part?

A Research Nurse will contact you to discuss this part of the study and answer any questions you may have. If you would like to join the study, they will ask you some questions about your health to make sure that you are safe to have the FAST MRI scan. They will help you complete an online consent form and book you in for your scan at a time convenient to you. This will need to be between day 6 and 16 of your cycle if you are still having regular periods.

What would stop me from having a FAST MRI scan?

Please let the Research Nurse know if you are affected by any of the below as these things may prevent you having an MRI scan:

  • If you are or may be pregnant or if you are breast feeding 
  • If you have ever had a penetrating eye injury
  • If you have ever had brain surgery
  • If you have a pacemaker or defibrillator
  • If you have an implanted neurostimulator
  • If you have a cochlear implant
  • If you have ever had a shrapnel injury
  • If you are claustrophobic
  • If you have had conditions associated with your kidneys
  • If you wear a sensor to measure your blood sugars (e.g. a “continuous glucose monitor”), this will need to be removed for the scan. We will try to arrange your scan around the time when you are due to change your sensor.

What is it like to have a FAST MRI scan?

We encourage you to watch this video to see what it is like to have a FAST MRI scan

Your FAST MRI scan appointment will take up to 45 minutes.

When you arrive, the radiographer will ask some questions to confirm that it’s safe for you to have the scan and ask you to sign a standard safety checklist. 

You will be asked to change into a hospital gown. 

You will have a cannula (a small, soft plastic tube) placed into a vein in your arm. This is necessary so that the radiographer can inject dye during your scan, which makes a cancer show up clearly if it’s there. The injection of dye is not painful. 

The radiographer will explain what is going to happen during the scan, which we expect to take between 3 and 5 minutes.

Once you have had the scan and your cannula has been removed, you will be free to go. Your scans will be sent to specialists who look at them in detail and check the findings. This means we can’t give you the results on the day of your scan.  

How will you get the results of your FAST MRI?

We will let you know the results of your FAST MRI scan 3-4 weeks after your scan date. 

If your scan is clear, you will receive your scan results by letter. 

Some people with a clear FAST MRI scan may be invited to have another scan in a year's time. This is because their scan is most likely normal but we would like to see if it has changed over time, as we are still learning which appearances on FAST MRI we can confidently call “clear”. We expect that all the people invited to have this second scan will then have a clear result.

If your scan shows that further investigations are needed, a Research Nurse will contact you by telephone to explain the results and what will happen next. The Research Nurse will arrange an appointment at the Breast Care Clinic. Appointments are usually offered within about 2 weeks of referral. This does not necessarily mean that you have a breast cancer, just that you need to have additional tests. You will receive a letter confirming the FAST MRI scan results.   

At these appointments a healthcare professional will look at your mammogram and FAST MRI scan results and will ask for more tests to be done, including another scan and possibly a biopsy. If you have a biopsy, we may ask you if we can collect an extra sample to donate to a tissue bank to help support future research. Information about this option will only be sent to you if you need further investigations following your FAST MRI.

They may also discuss your case with a team of other professionals after your appointment to help decide if more investigations are needed, which could include deciding to perform a full MRI. If you do need further tests, your care team will explain why each test is important and what having the test would involve for you. Any extra tests you may have will help the team decide if what was seen on the FAST MRI is a cancer or not.

We expect that if 100 people have a FAST MRI scan, 5 of those people will be called back for further investigations. Of those 5 people, we expect that only around 1 participant will be diagnosed with a cancer.

What are the possible benefits of taking part?

Taking part in the FAST MRI DYAMOND Study gives you access to a new test (a FAST MRI scan).

We do not know if your FAST MRI scan will pick up a cancer that was not found on your first mammogram. If it does, it is possible that you will have a better outcome, because the cancer will have been found earlier than it would have been if you had not taken part in the study. 

By taking part in this important study, you will be making a difference by helping us plan more research to improve breast screening for everyone in the future.

What are the possible disadvantages and risks of taking part?

We expect that the potential advantages of taking part will outweigh any disadvantages or risks.

Having an MRI scan is painless, and it’s one of the safest medical procedures available, but there are some risks. For example, there are increased risks to people with certain implants or foreign bodies. The Research Nurse and Radiographer will ask you questions about your medical history to check that you can have the scan. 

Some patients occasionally experience a tingling sensation or feel hot from being in the MRI scanner. These effects only last a short while and should ease as soon as the scan is over.

The scan involves having an injection of dye which is used to highlight any cancer cells (if a cancer is there). The risks associated with this injection are small and are well known: 

  • About 1 in every 100 people may have a mild reaction to this dye (such as pain at the injection site, nausea or headache) 
  • About 1 in 1000 people may experience vomiting and/or an itchy rash   
  • A more severe allergic rection is very rare, affecting about 1 in 10,000 people.  The radiographers who will be looking after you during your FAST MRI scan are trained to support individuals if this happens, and appropriate medical care will be given.  The dye is not recommended for people who are pregnant or breast feeding.
  • Tiny amounts of dye can stay in the body for a long time after the scan but this has never been shown to cause any problems.   

Will my GP be informed that I am taking part in the FAST MRI DYAMOND study?

If you decide to take part in the study, we will let your GP know and we will tell them the results of your scan when they are available.

Expenses and payments

You will not be paid for taking part in the FAST MRI DYAMOND study but reasonable expenses (up to £10) to attend your FAST MRI scan will be covered. Your Research Nurse will give you this information.

Further information about the FAST MRI DYAMOND study

In this study we will use information from you and from your medical records. We will only use information that we need for the research study. We will let very few DYAMOND team members know your name or contact details, and only if they really need it for this study. This includes research staff at Royal Surrey Hospital who are providing the Consent Form website. Everyone involved in this study will keep your data safe and secure. We will also follow all privacy rules.  At the end of the study, we will save some of the data for up to 5 years after the study closes, in case we need to check it and for future research (if you have given us permission). We will make sure no-one can work out who you are from the reports we write. Please contact us on the details below for more information about this. 

This study is run by Dr Lyn Jones (Consultant Radiologist) at the FAST MRI Programme Team at North Bristol NHS Trust.

DYAMOND web banner (1).png